Pilot early phase II study of decitabine and carboplatin in patients with advanced melanoma

por van der Westhuizen, Andre, Knoblauch, Naomi, Graves, Moira C., Levy, Richard, Vilain, Ricardo E., Bowden, Nikola A.
Publicado 2020

Low tumour-infiltrating lymphocyte density in primary and recurrent glioblastoma

por Maddison, Kelsey, Graves, Moira C., Bowden, Nikola A., Fay, Michael, Vilain, Ricardo E., Faulkner, Sam, Tooney, Paul A.
Publicado 2021

Repair of UVB-induced DNA damage is reduced in melanoma due to low XPC and global genome repair

por Budden, Timothy, Davey, Ryan J., Vilain, Ricardo E., Ashton, Katie A., Braye, Stephen G., Beveridge, Natalie J., Bowden, Nikola A.
Publicado 2016

Monitoring Patient Response to Pembrolizumab With Peripheral Blood Exhaustion Marker Profiles

por Graves, Moira, CelliMarchett, Giovana, van Zyl, Belinda, Tang, Denise, Vilain, Ricardo E., van der Westhuizen, Andre, Bowden, Nikola A.
Publicado 2019

PD-L1 expression in tonsillar cancer is associated with human papillomavirus positivity and improved survival: implications for anti-PD1 clinical trials

por Hong, Angela M, Vilain, Ricardo E, Romanes, Sarah, Yang, Jean, Smith, Elizabeth, Jones, Deanna, Scolyer, Richard A, Lee, C Soon, Zhang, Mei, Rose, Barbara
Publicado 2016

Repurposing Azacitidine and Carboplatin to Prime Immune Checkpoint Blockade–resistant Melanoma for Anti-PD-L1 Rechallenge

por van der Westhuizen, Andre, Lyle, Megan, Graves, Moira C., Zhu, Xiaoqiang, Wong, Jason W. H., Cornall, Kerrie, Ren, Shu, Pugliese, Leanna, Levy, Richard, Majid, Adeeb, Vilain, Ricardo E., Bowden, Nikola A.
Publicado 2022

Regulators of Global Genome Repair Do Not Respond to DNA Damaging Therapy but Correlate with Survival in Melanoma

por Bowden, Nikola A., Ashton, Katie A., Vilain, Ricardo E., Avery-Kiejda, Kelly A., Davey, Ryan J., Murray, Heather C., Budden, Timothy, Braye, Stephen G., Zhang, Xu Dong, Hersey, Peter, Scott, Rodney J.
Publicado 2013